Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Shire reports positive phase II results for Lambda

June 30, 1999

FDA approves 15-mg Ditropan XL tablets

June 30, 1999

Zeria designs dual-action arylpiperazines for BPH

June 28, 1999

WAY-133537: safe and effective agent for bladder instability

June 28, 1999

Merck describes new selective alpha1a-adrenoceptor blockers and use in BPH

June 21, 1999

Dutasteride suppresses DHT levels more effectively, consistently than finasteride

June 21, 1999

Substantially pure (S)-(+)-enantiomer form of ETA antagonist prepared at Pfizer

June 15, 1999

Imidazotriazinones synthesized at Bayer inhibit cGMP-PDE isozymes

June 14, 1999

Tricyclic cGMP-PDE inhibitors for urinary incontinence and related disorders

June 8, 1999

New compounds from SS Pharm. with greater bladder selectivity than oxybutynin

June 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...